Global Blood Glucose Monitoring Systems Market Size, Share, Forecast Report, 2020-2027

The global Blood Glucose Monitoring Systems market garnered revenue around USD 15.5 Billion in 2019 and projected to reach USD 25.1 Billion in 2027, with at a compound annual growth rate (CAGR) 5.6 % throughout the estimate period from 2020 to 2027. Blood glucose monitoring is used to analyze the concentration of glucose in the blood. Diabetes management is a vital procedure once a person is diagnosed with diabetes. Healthcare professionals recommend the patients to monitor the blood glucose level and their conditions. In terms of product, the global blood glucose monitoring systems market has been bifurcated into self-monitoring blood glucose systems and continuous glucose monitoring systems. The self-monitoring blood glucose systems segment captured the largest market share in 2019. The segment is expected to expand at the highest CAGR during the forecast period, owing to rise in prevalence of diabetes. The self-monitoring blood glucose systems segment has been split into blood glucose meters, testing strips, lancing devices, and lancets. The testing strips sub-segment accounted for the largest market share in 2019. The continuous glucose monitoring systems segment has been segregated into sensors, transmitters, and receivers. The sensors sub-segment held the largest market share in 2019. Based on application, the global blood glucose monitoring systems market has been categorized into type 1 diabetes, type 2 diabetes, and gestational diabetes.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Blood Glucose Monitoring Systems market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Blood Glucose Monitoring Systems market growth.

The global Blood Glucose Monitoring Systems market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

The global blood glucose monitoring systems market include Abbott, Medtronic, Hoffmann-La Roche Ltd., B. Braun Melsungen AG, AgaMatrix, Sanofi, SD Biosensor, Inc., LifeScan, Ascensia Diabetes Care, Prodigy Diabetes Care, LLC, Nipro, Dexcom, Inc., Ypsomed AG, Senseonics, and ACON Laboratories, Inc.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

Global Blood Glucose Monitoring Systems Market: Segmentation                                                                                                                                                                             

Blood Glucose Monitoring Systems Market, by Product

• Self-Monitoring Blood Glucose Systems
  • Blood Glucose Meters
  • Testing Strips
  • Lancing Devices
  • Lancets
• Continuous Glucose Monitoring Systems
  • Sensors
  • Transmitters
  • Receivers

Blood Glucose Monitoring Systems Market, by Application

• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

Blood Glucose Monitoring Systems Market, by Testing Site

• Fingertip Testing
• Alternate Site Testing

Blood Glucose Monitoring Systems Market, by Patient Care Setting

• Self/Home Care
• Hospitals
• Clinics

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA